Alere Inc delivers reliable and actionable information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally.The company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in-vitro diagnostic tests marketed to medical professionals and laboratories for the detection of diseases and conditions within its areas of focus.In 2016, Alere shareholders approved a merger with Abbott Laboratories.

In Israel, Alere acquired Orgenics, whichmanufactures and markets diagnostic tests. Ithas developed more than 25 tests for diseases, including viruses such as HIV and hepatitis.Today the company is known asAlere Connected Health Ltd.